{"created":"2024-11-07T01:32:27.056860+00:00","id":2000768,"links":{},"metadata":{"_buckets":{"deposit":"37185f1b-adf4-42f3-aaea-fb1e72e672ad"},"_deposit":{"created_by":172,"id":"2000768","owner":"172","owners":[172],"pid":{"revision_id":0,"type":"depid","value":"2000768"},"status":"published"},"_oai":{"id":"oai:iwatemed.repo.nii.ac.jp:02000768","sets":["17:254","23:37"]},"author_link":[],"control_number":"2000768","item_10003_biblio_info_7":{"attribute_name":"bibliographic_information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-09","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9 Suppl2","bibliographicPageStart":"S546","bibliographicVolumeNumber":"10","bibliographic_titles":[{"bibliographic_title":"Journal of Thoracic Oncology","bibliographic_titleLang":"en"}]}]},"item_10003_heading_23":{"attribute_name":"見出し","attribute_value_mlt":[{"subitem_heading_banner_headline":"医学部","subitem_heading_headline":"内科学（呼吸）","subitem_heading_language":"ja"}]},"item_10003_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier","subitem_publisher_language":"en"}]},"item_10003_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://www.jto.org/article/S1556-0864%2816%2930012-0/fulltext","subitem_relation_type_select":"URI"}}]},"item_10003_source_id_9":{"attribute_name":"item_10003_source_id_9","attribute_value_mlt":[{"subitem_source_identifier":"1556-0864","subitem_source_identifier_type":"PISSN"}]},"item_10003_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_be7fb7dd8ff6fe43","subitem_version_type":"NA"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yokouchi, Hiroshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takashina, Taichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Asahina, Hajime","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yamada, Noriyuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Harada, Masao","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nakano, Kosuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kanazawa, Kenya","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takamura, Kei","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ogi, Takahiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Harada, Toshiyuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Honjo, Osamu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Morikawa, Naoto","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kinoshita, Ichiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Honda, Ryoichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Amano, Toraji","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Dosaka-Akita, Hirotoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Isobe, Hiroshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nishimura, Masaharu","creatorNameLang":"en"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"conference paper","resourceuri":"http://purl.org/coar/resource_type/c_5794"}]},"item_title":"A Phase II Study of Carboplatin/Pemetrexed/Bevacizumab Followed by Bevacizumab/Erlotinib Maintenance for NonSq-NSCLC with Wild-Type EGFR","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"A Phase II Study of Carboplatin/Pemetrexed/Bevacizumab Followed by Bevacizumab/Erlotinib Maintenance for NonSq-NSCLC with Wild-Type EGFR","subitem_title_language":"en"}]},"item_type_id":"10003","owner":"172","path":["254","37"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-11-07"},"publish_date":"2024-11-07","publish_status":"0","recid":"2000768","relation_version_is_last":true,"title":["A Phase II Study of Carboplatin/Pemetrexed/Bevacizumab Followed by Bevacizumab/Erlotinib Maintenance for NonSq-NSCLC with Wild-Type EGFR"],"weko_creator_id":"172","weko_shared_id":-1},"updated":"2024-11-08T07:38:07.419241+00:00"}